Clinical Trial Update: S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update of lapatinib combined with everolimus in patients with advanced solid tumors or Non-Hodgkin's lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Everolimus (everolimus)
• Lapatinib (Lapatinib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Status: COMPLETED